🇨🇦·15h agoIndustry
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026
Publisher
Z
Zymeworks
Canada
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Zymeworks
- Region
- Canada
- Scope
- Industry
- Published
- June 15, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on ir.zymeworks.com
Leave the platform to read the original full article on the publisher site.
Source: Zymeworks
Scope: Industry
Related coverage
More related coverage
Aptose Biosciences·2h ago
Aptose Presents Safety, Response, and MRD Clinical Data from TUSCANY Phase 1/2 Clinical Trial of Tuspetinib Triplet Therapy in Newly Diagnosed AML at the 2026 EHA Congress in Oral Presentation
Tiziana Life Sciences·3h ago
Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman
Adial Pharmaceuticals·3d ago
Adial Pharmaceuticals Announces Acquisition of Azora Therapeutics and up to $64 Million Financing
Adial Pharmaceuticals·3d ago